• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.

作者信息

Laxman Bharathi, Tomlins Scott A, Mehra Rohit, Morris David S, Wang Lei, Helgeson Beth E, Shah Rajal B, Rubin Mark A, Wei John T, Chinnaiyan Arul M

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

出版信息

Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.

DOI:10.1593/neo.06625
PMID:17059688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1715928/
Abstract

We recently reported the identification of recurrent gene fusions in the majority of prostate cancers involving the 5' untranslated region of the androgen-regulated gene TMPRSS2 and the ETS family members ERG, ETV1, and ETV4. Here we report the noninvasive detection of these gene fusions in the urine of patients with clinically localized prostate cancer. By quantitative polymerase chain reaction, we assessed the expression of ERG and TMPRSS2:ERG transcripts in urine samples obtained after prostatic massage from 19 patients (11 prebiopsy and 8 pre-radical prostatectomy) with prostate cancer. We observed a strong concordance between ERG overexpression and TMPRSS2:ERG expression, with 8 of 19 (42%) patients having detectable TMPRSS2:ERG transcripts in their urine. Importantly, by fluorescence in situ hybridization, we confirmed the presence or the absence of TMPRSS2:ERG gene fusions in matched prostate cancer tissue samples from three of three patients with fusion transcripts in their urine and from two of two patients without fusion transcripts in their urine. These results demonstrate that TMPRSS2:ERG gene fusions can be detected in the urine of patients with prostate cancer and support larger studies on prospective cohorts for noninvasive detection of prostate cancer.

摘要

我们最近报告称,在大多数前列腺癌中发现了复发性基因融合,这些融合涉及雄激素调节基因TMPRSS2的5'非翻译区以及ETS家族成员ERG、ETV1和ETV4。在此,我们报告了在临床局限性前列腺癌患者尿液中对这些基因融合的非侵入性检测。通过定量聚合酶链反应,我们评估了19例前列腺癌患者(11例活检前和8例根治性前列腺切除术前)前列腺按摩后获得的尿液样本中ERG和TMPRSS2:ERG转录本的表达。我们观察到ERG过表达与TMPRSS2:ERG表达之间有很强的一致性,19例患者中有8例(42%)尿液中可检测到TMPRSS2:ERG转录本。重要的是,通过荧光原位杂交,我们在尿液中有融合转录本的3例患者中的3例以及尿液中无融合转录本的2例患者中的2例的匹配前列腺癌组织样本中证实了TMPRSS2:ERG基因融合的存在或不存在。这些结果表明,前列腺癌患者尿液中可检测到TMPRSS2:ERG基因融合,并支持对前列腺癌非侵入性检测的前瞻性队列进行更大规模的研究。

相似文献

1
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测
Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.
2
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.通过易位或间质性缺失形成的TMPRSS2:ERG融合在雄激素依赖性前列腺癌中高度相关,但在晚期雄激素受体阴性前列腺癌中则不存在。
Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871.
3
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.中国东部前列腺癌患者的TMPRSS2:ETS融合与临床病理特征
Asian Pac J Cancer Prev. 2014;15(7):3099-103. doi: 10.7314/apjcp.2014.15.7.3099.
4
TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.TMPRSS2/ERG融合基因表达改变雄激素非依赖性前列腺癌细胞培养模型中的化学敏感性和放射敏感性。
Prostate. 2011 Oct 1;71(14):1548-58. doi: 10.1002/pros.21371. Epub 2011 Mar 10.
5
ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples.ETS 家族相关基因融合在日本前列腺癌中的研究:194 例根治性前列腺切除术样本分析。
Mod Pathol. 2010 Nov;23(11):1492-8. doi: 10.1038/modpathol.2010.149. Epub 2010 Aug 6.
6
Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer.50例前列腺癌中TMPRSS2-ERG和TMPRSS2-ETV1基因融合的分子遗传学分析。
Oncol Rep. 2007 May;17(5):1033-6.
7
TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis.前列腺癌患者尿液中的TMPRSS2:ERG融合转录本与较差的预后相关。
APMIS. 2009 Aug;117(8):575-82. doi: 10.1111/j.1600-0463.2009.02517.x.
8
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.前列腺癌中TMPRSS2/ERG融合的三色荧光原位杂交分析表明,21号染色体的基因组微缺失与重排有关。
Neoplasia. 2006 Jun;8(6):465-9. doi: 10.1593/neo.06283.
9
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.前列腺癌中TMPRSS2与ETS家族基因之间的基因融合:通过对石蜡包埋组织进行RT-PCR和FISH分析其频率及转录本变体
Mod Pathol. 2007 Sep;20(9):921-8. doi: 10.1038/modpathol.3800903. Epub 2007 Jul 13.
10
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.TMPRSS2-ERG基因融合前列腺癌的形态学特征。
J Pathol. 2007 May;212(1):91-101. doi: 10.1002/path.2154.

引用本文的文献

1
MXene and prostate cancer: is there promising news?MXene与前列腺癌:有好消息吗?
Nanomedicine (Lond). 2025 May;20(9):1001-1014. doi: 10.1080/17435889.2025.2487412. Epub 2025 Apr 16.
2
New biomarkers and multiplex tests for diagnosis of aggressive prostate cancer and therapy management.用于侵袭性前列腺癌诊断和治疗管理的新型生物标志物及多重检测
Front Oncol. 2025 Feb 25;15:1542511. doi: 10.3389/fonc.2025.1542511. eCollection 2025.
3
Nurturing the marriages of urinary liquid biopsies and nano-diagnostics for precision urinalysis of prostate cancer.培育尿液液体活检与纳米诊断技术的结合,用于前列腺癌的精准尿液分析。
Smart Med. 2023 Feb 14;2(1):e20220020. doi: 10.1002/SMMD.20220020. eCollection 2023 Feb.
4
Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications.前列腺癌测序与组学研究进展:揭示分子发病机制及临床应用
Front Oncol. 2024 May 10;14:1355551. doi: 10.3389/fonc.2024.1355551. eCollection 2024.
5
Clinical Biofluid Assays for Prostate Cancer.前列腺癌的临床生物流体检测
Cancers (Basel). 2023 Dec 28;16(1):165. doi: 10.3390/cancers16010165.
6
Targeted Mass Spectrometry Assays for Specific Quantification of Urinary proPSA Isoforms.针对尿游离前列腺特异性抗原同工型的靶向质谱分析检测。
J Proteome Res. 2023 Mar 3;22(3):942-950. doi: 10.1021/acs.jproteome.2c00745. Epub 2023 Jan 10.
7
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer.影像技术及TMPRSS2:ERG突变在临床显著性前列腺癌诊断中作用的前瞻性评估
Front Oncol. 2022 Sep 6;12:968384. doi: 10.3389/fonc.2022.968384. eCollection 2022.
8
Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives.前列腺癌管理中的液体活检——当前挑战与未来展望
Cancers (Basel). 2022 Jul 4;14(13):3272. doi: 10.3390/cancers14133272.
9
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer.靶向ERG融合阳性前列腺癌的过去、当前及未来策略
Cancers (Basel). 2022 Feb 22;14(5):1118. doi: 10.3390/cancers14051118.
10
Beyond Prostate Specific Antigen: New Prostate Cancer Screening Options.超越前列腺特异性抗原:前列腺癌筛查的新选择。
World J Mens Health. 2022 Jan;40(1):66-73. doi: 10.5534/wjmh.210076.

本文引用的文献

1
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer.变异型TMPRSS2/ERG融合信使核糖核酸的表达与侵袭性前列腺癌相关。
Cancer Res. 2006 Sep 1;66(17):8347-51. doi: 10.1158/0008-5472.CAN-06-1966.
2
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.TMPRSS2:ERG融合相关缺失为深入了解前列腺癌的异质性提供了线索。
Cancer Res. 2006 Sep 1;66(17):8337-41. doi: 10.1158/0008-5472.CAN-06-1482.
3
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.前列腺癌中TMPRSS2/ERG融合的三色荧光原位杂交分析表明,21号染色体的基因组微缺失与重排有关。
Neoplasia. 2006 Jun;8(6):465-9. doi: 10.1593/neo.06283.
4
Whole transcriptome amplification for gene expression profiling and development of molecular archives.用于基因表达谱分析和分子档案建立的全转录组扩增
Neoplasia. 2006 Feb;8(2):153-62. doi: 10.1593/neo.05754.
5
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.TMPRSS2:ETV4基因融合定义了前列腺癌的第三种分子亚型。
Cancer Res. 2006 Apr 1;66(7):3396-400. doi: 10.1158/0008-5472.CAN-06-0168.
6
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.前列腺癌中TMPRSS2/ERG融合基因高频率的确认。
Genes Chromosomes Cancer. 2006 Jul;45(7):717-9. doi: 10.1002/gcc.20329.
7
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.前列腺癌中TMPRSS2与ETS转录因子基因的反复融合
Science. 2005 Oct 28;310(5748):644-8. doi: 10.1126/science.1117679.
8
Vysis UroVysion for the detection of urothelial carcinoma.用于检测尿路上皮癌的Vysis UroVysion检测法
Expert Rev Mol Diagn. 2003 Jul;3(4):507-19. doi: 10.1586/14737159.3.4.507.
9
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.通过多个内参基因的几何平均对实时定量逆转录聚合酶链反应数据进行准确标准化。
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034.
10
Chromosome translocations: dangerous liaisons revisited.染色体易位:重温危险的关联
Nat Rev Cancer. 2001 Dec;1(3):245-50. doi: 10.1038/35106108.